Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes

'Smart' CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels;
Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management

DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in med... Devices, Monitoring, Endocrinology, FDA Medtronic, Guardian Connect, Continuous Glucose Monitoring, diabetes

Source: HSMN NewsFeed - March 12, 2018 Category: Pharmaceuticals Source Type: news